Você está em: Start > Publications > Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug > View related publications
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto
I Terms and Conditions
I Acessibility
I Index A-Z
Page created on: 2025-09-25 at 00:59:25 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book
Page created on: 2025-09-25 at 00:59:25 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book